[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Impact of Chronic Kidney Disease on In-Hospital Outcomes and Resource Utilization Among Patients Hospitalized for AMI",
    "section": "",
    "text": "Reference Papers:\n\nSmilowitz et al. 2017\nSalman et al. 2025\n\nStudy Objective: To examine the association between chronic kidney disease (CKD) and inpatient outcomes for acute myocardial infarction (AMI) in U.S. hospitals from 2018 to 2020, adjusting for demographic, socioeconomic, clinical, and hospital-related factors.\nData Source: Cross-sectional analysis using the National Inpatient Sample (NIS) database from 2018 to 2020, a representative sample of all-payer inpatient hospitalizations in the U.S.\nPatient Selection: Included all inpatient admissions for AMI, identified using ICD-10 diagnosis codes. Patients were categorized into two groups: those with CKD and those without.\nOutcomes of Interest:\n\nIn-hospital Mortality\nLength of Stay (days)\nInflation-adjusted Total Charge ($) [adjusted to 2020 dollars, using CPI data by the U.S. Bureau of Labor Statistics]\nCoronary Artery Bypass Grafting (CABG) Procedure\nPercutaneous Coronary Intervention (PCI) Procedure\nAcute Kidney Injury (AKI)\nIschemic Stroke\n\nStatistical Analysis: Univariable and multivariable analyses were conducted to evaluate the association between race and outcomes:\n\nUnivariable Analysis:\n\nContinuous variables: Design-based Kruskal-Wallis test.\nCategorical variables: Pearson’s X² test with Rao & Scott adjustment to account for survey design.\n\nMultivariable Analysis:\n\nLogistic regression for binary outcomes (e.g., in-hospital mortality, AKI, ischemic stroke).\nLinear regression for continuous outcomes (e.g., length of stay, total charges).\n\nAdjustments: Models controlled for the following covariates:\n\nDemographics and Socioeconomic Factors: Age, Sex, Race, Residential income, Expected primary payer.\nClinical Factors: Charlson comorbidity index, Hypertension, Obesity, Diabetes Mellitus, Chronic Pulmonary Disease, Liver Disease, Peripheral Vascular Disease, Hyperlipidemia, Previous Heart Failure, Atrial Fibrillation, Smoking, Previous Stroke/TIA, Previous PCI, Previous CABG.\nHospital-Level Factors: Hospital region, Hospital bedsize, Hospital location and teaching status.\n\n\nSoftware: All statistical analyses were performed using R Statistical Language (Version 4.5.0; R Foundation for Statistical Computing, Vienna, Austria), incorporating survey-weighted procedures via the survey package to account for the complex sampling design of NIS."
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Impact of Chronic Kidney Disease on In-Hospital Outcomes and Resource Utilization Among Patients Hospitalized for AMI",
    "section": "",
    "text": "Reference Papers:\n\nSmilowitz et al. 2017\nSalman et al. 2025\n\nStudy Objective: To examine the association between chronic kidney disease (CKD) and inpatient outcomes for acute myocardial infarction (AMI) in U.S. hospitals from 2018 to 2020, adjusting for demographic, socioeconomic, clinical, and hospital-related factors.\nData Source: Cross-sectional analysis using the National Inpatient Sample (NIS) database from 2018 to 2020, a representative sample of all-payer inpatient hospitalizations in the U.S.\nPatient Selection: Included all inpatient admissions for AMI, identified using ICD-10 diagnosis codes. Patients were categorized into two groups: those with CKD and those without.\nOutcomes of Interest:\n\nIn-hospital Mortality\nLength of Stay (days)\nInflation-adjusted Total Charge ($) [adjusted to 2020 dollars, using CPI data by the U.S. Bureau of Labor Statistics]\nCoronary Artery Bypass Grafting (CABG) Procedure\nPercutaneous Coronary Intervention (PCI) Procedure\nAcute Kidney Injury (AKI)\nIschemic Stroke\n\nStatistical Analysis: Univariable and multivariable analyses were conducted to evaluate the association between race and outcomes:\n\nUnivariable Analysis:\n\nContinuous variables: Design-based Kruskal-Wallis test.\nCategorical variables: Pearson’s X² test with Rao & Scott adjustment to account for survey design.\n\nMultivariable Analysis:\n\nLogistic regression for binary outcomes (e.g., in-hospital mortality, AKI, ischemic stroke).\nLinear regression for continuous outcomes (e.g., length of stay, total charges).\n\nAdjustments: Models controlled for the following covariates:\n\nDemographics and Socioeconomic Factors: Age, Sex, Race, Residential income, Expected primary payer.\nClinical Factors: Charlson comorbidity index, Hypertension, Obesity, Diabetes Mellitus, Chronic Pulmonary Disease, Liver Disease, Peripheral Vascular Disease, Hyperlipidemia, Previous Heart Failure, Atrial Fibrillation, Smoking, Previous Stroke/TIA, Previous PCI, Previous CABG.\nHospital-Level Factors: Hospital region, Hospital bedsize, Hospital location and teaching status.\n\n\nSoftware: All statistical analyses were performed using R Statistical Language (Version 4.5.0; R Foundation for Statistical Computing, Vienna, Austria), incorporating survey-weighted procedures via the survey package to account for the complex sampling design of NIS."
  },
  {
    "objectID": "quarto/index.html#baseline-table",
    "href": "quarto/index.html#baseline-table",
    "title": "Impact of Chronic Kidney Disease on In-Hospital Outcomes and Resource Utilization Among Patients Hospitalized for AMI",
    "section": "Baseline Table:",
    "text": "Baseline Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall\nN = 1,894,1601\nAMI without CKD\nN = 1,433,0351\nAMI with CKD\nN = 461,1251\np-value2\n\n\n\n\nAge, y\n67 (13)\n65 (13)\n72 (12)\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n&lt;0.001\n\n\n    Female\n702,145 (37%)\n526,065 (37%)\n176,080 (38%)\n\n\n\n\n    Male\n1,191,940 (63%)\n906,910 (63%)\n285,030 (62%)\n\n\n\n\nRace\n\n\n\n\n\n\n&lt;0.001\n\n\n    White\n1,344,600 (73%)\n1,040,180 (75%)\n304,420 (68%)\n\n\n\n\n    Asian or Pacific Islander\n52,155 (2.8%)\n35,655 (2.6%)\n16,500 (3.7%)\n\n\n\n\n    Black\n210,205 (11%)\n139,850 (10%)\n70,355 (16%)\n\n\n\n\n    Hispanic\n165,065 (9.0%)\n121,320 (8.7%)\n43,745 (9.7%)\n\n\n\n\n    Native American\n11,255 (0.6%)\n8,225 (0.6%)\n3,030 (0.7%)\n\n\n\n\n    Other\n56,120 (3.1%)\n44,010 (3.2%)\n12,110 (2.7%)\n\n\n\n\nResidential income\n\n\n\n\n\n\n&lt;0.001\n\n\n    $1 - $51,999\n571,040 (31%)\n425,545 (30%)\n145,495 (32%)\n\n\n\n\n    $52,000 - $65,999\n515,875 (28%)\n390,375 (28%)\n125,500 (28%)\n\n\n\n\n    $66,000 - $87,999\n435,135 (23%)\n331,000 (24%)\n104,135 (23%)\n\n\n\n\n    $88,000 or more\n338,645 (18%)\n260,000 (18%)\n78,645 (17%)\n\n\n\n\nExpected primary payer\n\n\n\n\n\n\n&lt;0.001\n\n\n    Medicaid\n182,120 (9.6%)\n150,500 (11%)\n31,620 (6.9%)\n\n\n\n\n    Medicare\n1,068,990 (57%)\n718,720 (50%)\n350,270 (76%)\n\n\n\n\n    Other\n156,150 (8.3%)\n135,695 (9.5%)\n20,455 (4.4%)\n\n\n\n\n    Private\n484,075 (26%)\n425,780 (30%)\n58,295 (13%)\n\n\n\n\nHospital region\n\n\n\n\n\n\n&lt;0.001\n\n\n    Midwest\n423,055 (22%)\n314,560 (22%)\n108,495 (24%)\n\n\n\n\n    Northeast\n321,135 (17%)\n246,235 (17%)\n74,900 (16%)\n\n\n\n\n    South\n785,340 (41%)\n600,715 (42%)\n184,625 (40%)\n\n\n\n\n    West\n364,630 (19%)\n271,525 (19%)\n93,105 (20%)\n\n\n\n\nHospital bedsize\n\n\n\n\n\n\n0.7\n\n\n    Large\n953,780 (50%)\n721,050 (50%)\n232,730 (50%)\n\n\n\n\n    Medium\n574,065 (30%)\n435,025 (30%)\n139,040 (30%)\n\n\n\n\n    Small\n366,315 (19%)\n276,960 (19%)\n89,355 (19%)\n\n\n\n\nHospital location and teaching status\n\n\n\n\n\n\n&lt;0.001\n\n\n    Rural\n143,995 (7.6%)\n109,840 (7.7%)\n34,155 (7.4%)\n\n\n\n\n    Urban, non-teaching\n371,575 (20%)\n283,550 (20%)\n88,025 (19%)\n\n\n\n\n    Urban, teaching\n1,378,590 (73%)\n1,039,645 (73%)\n338,945 (74%)\n\n\n\n\nCharlson comorbidity index\n3.18 (2.03)\n2.36 (1.39)\n5.72 (1.56)\n&lt;0.001\n\n\nChronic Kidney Disease Stage\n\n\n\n\n\n\n\n\n\n\n    CKD, Stage 1\n2,360 (0.6%)\n0 (NA%)\n2,360 (0.6%)\n\n\n\n\n    CKD, Stage 2\n25,125 (6.7%)\n0 (NA%)\n25,125 (6.7%)\n\n\n\n\n    CKD, Stage 3\n205,455 (55%)\n0 (NA%)\n205,455 (55%)\n\n\n\n\n    CKD, Stage 4\n52,400 (14%)\n0 (NA%)\n52,400 (14%)\n\n\n\n\n    CKD, Stage 5\n6,325 (1.7%)\n0 (NA%)\n6,325 (1.7%)\n\n\n\n\n    ESRD\n81,195 (22%)\n0 (NA%)\n81,195 (22%)\n\n\n\n\nHypertension\n1,555,090 (82%)\n1,115,635 (78%)\n439,455 (95%)\n&lt;0.001\n\n\nObesity\n404,395 (21%)\n302,975 (21%)\n101,420 (22%)\n&lt;0.001\n\n\nDiabetes Mellitus\n780,095 (41%)\n497,495 (35%)\n282,600 (61%)\n&lt;0.001\n\n\nChronic Pulmonary Disease\n410,215 (22%)\n289,505 (20%)\n120,710 (26%)\n&lt;0.001\n\n\nLiver Disease\n78,840 (4.2%)\n55,145 (3.8%)\n23,695 (5.1%)\n&lt;0.001\n\n\nPeripheral Vascular Disease\n213,740 (11%)\n135,125 (9.4%)\n78,615 (17%)\n&lt;0.001\n\n\nHyperlipidemia\n1,298,935 (69%)\n968,565 (68%)\n330,370 (72%)\n&lt;0.001\n\n\nPrevious Heart Failure\n268,755 (14%)\n160,705 (11%)\n108,050 (23%)\n&lt;0.001\n\n\nAtrial Fibrillation\n381,615 (20%)\n245,950 (17%)\n135,665 (29%)\n&lt;0.001\n\n\nSmoking\n379,510 (20%)\n328,740 (23%)\n50,770 (11%)\n&lt;0.001\n\n\nPrevious Stroke/TIA\n188,515 (10.0%)\n118,210 (8.2%)\n70,305 (15%)\n&lt;0.001\n\n\nPrevious PCI\n330,160 (17%)\n230,405 (16%)\n99,755 (22%)\n&lt;0.001\n\n\nPrevious CABG\n182,995 (9.7%)\n111,870 (7.8%)\n71,125 (15%)\n&lt;0.001\n\n\n\n1 Mean (SD); n (%)\n\n\n2 Design-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment"
  },
  {
    "objectID": "quarto/index.html#univariable-analysis",
    "href": "quarto/index.html#univariable-analysis",
    "title": "Impact of Chronic Kidney Disease on In-Hospital Outcomes and Resource Utilization Among Patients Hospitalized for AMI",
    "section": "Univariable Analysis:",
    "text": "Univariable Analysis:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall\nN = 1,894,1601\nAMI without CKD\nN = 1,433,0351\nAMI with CKD\nN = 461,1251\np-value2\n\n\n\n\nDied during hospitalization\n88,290 (4.7%)\n55,985 (3.9%)\n32,305 (7.0%)\n&lt;0.001\n\n\nLength of stay (days)\n3.0 (2.0, 5.0)\n2.0 (2.0, 4.0)\n4.0 (2.0, 7.0)\n&lt;0.001\n\n\nInflation-adjusted total charge ($)\n72,340 (40,656, 126,134)\n72,552 (41,977, 123,296)\n71,592 (36,558, 136,576)\n0.4\n\n\nCABG\n168,650 (8.9%)\n129,120 (9.0%)\n39,530 (8.6%)\n&lt;0.001\n\n\nPCI\n931,570 (49%)\n764,595 (53%)\n166,975 (36%)\n&lt;0.001\n\n\nAcute Kidney Injury\n392,175 (21%)\n181,175 (13%)\n211,000 (46%)\n&lt;0.001\n\n\nIschemic Stroke\n23,795 (1.3%)\n16,735 (1.2%)\n7,060 (1.5%)\n&lt;0.001\n\n\n\n1 n (%); Median (Q1, Q3)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment; Design-based KruskalWallis test"
  },
  {
    "objectID": "quarto/index.html#multivariable-logistic-regression",
    "href": "quarto/index.html#multivariable-logistic-regression",
    "title": "Impact of Chronic Kidney Disease on In-Hospital Outcomes and Resource Utilization Among Patients Hospitalized for AMI",
    "section": "Multivariable Logistic Regression:",
    "text": "Multivariable Logistic Regression:\n\nIn-hospital Mortality:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nChronic Kidney Disease\n\n\n\n\n\n\n\n\n    AMI without CKD\n—\n—\n\n\n\n\n    AMI with CKD\n1.03\n0.98, 1.08\n0.3\n\n\nAge, y\n1.04\n1.04, 1.04\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.97\n0.93, 1.00\n0.053\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.16\n1.06, 1.27\n0.001\n\n\n    Black\n0.97\n0.92, 1.03\n0.3\n\n\n    Hispanic\n0.94\n0.89, 1.00\n0.053\n\n\n    Native American\n1.09\n0.89, 1.34\n0.4\n\n\n    Other\n1.20\n1.10, 1.31\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.99\n0.95, 1.04\n0.7\n\n\n    $66,000 - $87,999\n0.96\n0.91, 1.00\n0.062\n\n\n    $88,000 or more\n0.94\n0.89, 0.99\n0.018\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Medicaid\n—\n—\n\n\n\n\n    Medicare\n0.94\n0.87, 1.01\n0.10\n\n\n    Other\n1.18\n1.08, 1.29\n&lt;0.001\n\n\n    Private\n0.85\n0.79, 0.92\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.98\n0.93, 1.03\n0.5\n\n\n    South\n1.06\n1.02, 1.11\n0.008\n\n\n    West\n1.06\n1.00, 1.12\n0.034\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.91\n0.88, 0.95\n&lt;0.001\n\n\n    Small\n0.79\n0.75, 0.83\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.11\n1.03, 1.20\n0.005\n\n\n    Urban, teaching\n1.30\n1.22, 1.39\n&lt;0.001\n\n\nCharlson comorbidity index\n1.15\n1.13, 1.16\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.63\n0.60, 0.66\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.77\n0.73, 0.81\n&lt;0.001\n\n\nDiabetes Mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.96\n0.92, 1.00\n0.081\n\n\nChronic Pulmonary Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.92\n0.88, 0.96\n&lt;0.001\n\n\nLiver Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n5.59\n5.31, 5.89\n&lt;0.001\n\n\nPeripheral Vascular Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.09\n1.03, 1.14\n0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.49\n0.47, 0.51\n&lt;0.001\n\n\nPrevious Heart Failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.84\n0.80, 0.88\n&lt;0.001\n\n\nAtrial Fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.34\n1.29, 1.39\n&lt;0.001\n\n\nSmoking\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.79\n0.75, 0.84\n&lt;0.001\n\n\nPrevious Stroke/TIA\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.99\n0.94, 1.05\n0.8\n\n\nPrevious PCI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.75\n0.72, 0.79\n&lt;0.001\n\n\nPrevious CABG\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.93\n0.88, 0.99\n0.017\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nCABG:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nChronic Kidney Disease\n\n\n\n\n\n\n\n\n    AMI without CKD\n—\n—\n\n\n\n\n    AMI with CKD\n0.75\n0.72, 0.79\n&lt;0.001\n\n\nAge, y\n0.99\n0.99, 0.99\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.76\n1.72, 1.81\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.18\n1.09, 1.28\n&lt;0.001\n\n\n    Black\n0.65\n0.61, 0.68\n&lt;0.001\n\n\n    Hispanic\n0.92\n0.87, 0.98\n0.008\n\n\n    Native American\n1.14\n0.96, 1.36\n0.13\n\n\n    Other\n0.99\n0.91, 1.08\n0.8\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1.03\n0.99, 1.07\n0.2\n\n\n    $66,000 - $87,999\n0.95\n0.90, 0.99\n0.016\n\n\n    $88,000 or more\n0.92\n0.87, 0.98\n0.006\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Medicaid\n—\n—\n\n\n\n\n    Medicare\n1.06\n1.00, 1.11\n0.033\n\n\n    Other\n1.05\n0.99, 1.12\n0.10\n\n\n    Private\n1.12\n1.07, 1.18\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.95\n0.88, 1.03\n0.2\n\n\n    South\n1.25\n1.16, 1.33\n&lt;0.001\n\n\n    West\n0.94\n0.87, 1.02\n0.13\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.66\n0.62, 0.70\n&lt;0.001\n\n\n    Small\n0.44\n0.41, 0.48\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n2.06\n1.70, 2.50\n&lt;0.001\n\n\n    Urban, teaching\n3.82\n3.20, 4.55\n&lt;0.001\n\n\nCharlson comorbidity index\n1.06\n1.04, 1.07\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.38\n1.32, 1.44\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.46\n1.42, 1.51\n&lt;0.001\n\n\nDiabetes Mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.37\n1.33, 1.42\n&lt;0.001\n\n\nChronic Pulmonary Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.05\n1.01, 1.09\n0.008\n\n\nLiver Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.02\n0.96, 1.09\n0.4\n\n\nPeripheral Vascular Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.22\n1.17, 1.28\n&lt;0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.55\n1.49, 1.61\n&lt;0.001\n\n\nPrevious Heart Failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.66\n0.63, 0.68\n&lt;0.001\n\n\nAtrial Fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.67\n2.59, 2.75\n&lt;0.001\n\n\nSmoking\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.99\n0.96, 1.02\n0.5\n\n\nPrevious Stroke/TIA\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.77\n0.73, 0.80\n&lt;0.001\n\n\nPrevious PCI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.71\n0.68, 0.74\n&lt;0.001\n\n\nPrevious CABG\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.16\n0.15, 0.18\n&lt;0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nPCI:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nChronic Kidney Disease\n\n\n\n\n\n\n\n\n    AMI without CKD\n—\n—\n\n\n\n\n    AMI with CKD\n1.09\n1.06, 1.12\n&lt;0.001\n\n\nAge, y\n0.99\n0.99, 0.99\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.41\n1.39, 1.43\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n0.81\n0.78, 0.85\n&lt;0.001\n\n\n    Black\n0.65\n0.63, 0.67\n&lt;0.001\n\n\n    Hispanic\n0.78\n0.75, 0.80\n&lt;0.001\n\n\n    Native American\n0.97\n0.88, 1.07\n0.5\n\n\n    Other\n1.00\n0.95, 1.05\n0.9\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1.04\n1.01, 1.06\n0.002\n\n\n    $66,000 - $87,999\n1.06\n1.04, 1.09\n&lt;0.001\n\n\n    $88,000 or more\n1.06\n1.03, 1.09\n&lt;0.001\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Medicaid\n—\n—\n\n\n\n\n    Medicare\n1.18\n1.15, 1.22\n&lt;0.001\n\n\n    Other\n1.19\n1.15, 1.23\n&lt;0.001\n\n\n    Private\n1.30\n1.26, 1.34\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.74\n0.71, 0.78\n&lt;0.001\n\n\n    South\n0.87\n0.84, 0.90\n&lt;0.001\n\n\n    West\n0.83\n0.80, 0.87\n&lt;0.001\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.87\n0.85, 0.90\n&lt;0.001\n\n\n    Small\n0.68\n0.65, 0.71\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.36\n1.27, 1.45\n&lt;0.001\n\n\n    Urban, teaching\n1.67\n1.57, 1.77\n&lt;0.001\n\n\nCharlson comorbidity index\n0.84\n0.84, 0.85\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.90\n0.89, 0.92\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.95\n0.93, 0.97\n&lt;0.001\n\n\nDiabetes Mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.21\n1.19, 1.23\n&lt;0.001\n\n\nChronic Pulmonary Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.88\n0.87, 0.90\n&lt;0.001\n\n\nLiver Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.96, 1.03\n0.9\n\n\nPeripheral Vascular Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.97\n0.94, 0.99\n0.010\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.44\n1.41, 1.46\n&lt;0.001\n\n\nPrevious Heart Failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.72\n0.70, 0.73\n&lt;0.001\n\n\nAtrial Fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.62\n0.60, 0.63\n&lt;0.001\n\n\nSmoking\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.27\n1.24, 1.29\n&lt;0.001\n\n\nPrevious Stroke/TIA\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.84\n0.82, 0.86\n&lt;0.001\n\n\nPrevious PCI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.94\n0.92, 0.96\n&lt;0.001\n\n\nPrevious CABG\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.72\n0.70, 0.74\n&lt;0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nAcute Kidney Injury:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nChronic Kidney Disease\n\n\n\n\n\n\n\n\n    AMI without CKD\n—\n—\n\n\n\n\n    AMI with CKD\n3.00\n2.91, 3.10\n&lt;0.001\n\n\nAge, y\n1.02\n1.02, 1.02\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.25\n1.23, 1.28\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.04\n0.99, 1.10\n0.12\n\n\n    Black\n1.19\n1.15, 1.23\n&lt;0.001\n\n\n    Hispanic\n1.03\n0.99, 1.07\n0.2\n\n\n    Native American\n0.89\n0.79, 1.00\n0.052\n\n\n    Other\n1.12\n1.06, 1.18\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.98\n0.96, 1.01\n0.13\n\n\n    $66,000 - $87,999\n0.98\n0.95, 1.00\n0.086\n\n\n    $88,000 or more\n0.99\n0.95, 1.02\n0.4\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Medicaid\n—\n—\n\n\n\n\n    Medicare\n0.75\n0.72, 0.78\n&lt;0.001\n\n\n    Other\n0.87\n0.83, 0.91\n&lt;0.001\n\n\n    Private\n0.74\n0.71, 0.77\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.97\n0.93, 1.01\n0.15\n\n\n    South\n1.10\n1.07, 1.14\n&lt;0.001\n\n\n    West\n0.99\n0.95, 1.03\n0.6\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.94\n0.91, 0.96\n&lt;0.001\n\n\n    Small\n0.87\n0.84, 0.90\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.23\n1.16, 1.29\n&lt;0.001\n\n\n    Urban, teaching\n1.44\n1.37, 1.51\n&lt;0.001\n\n\nCharlson comorbidity index\n1.20\n1.19, 1.21\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.04\n1.02, 1.08\n0.003\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.13\n1.11, 1.16\n&lt;0.001\n\n\nDiabetes Mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.01\n0.99, 1.03\n0.5\n\n\nChronic Pulmonary Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.92\n0.90, 0.95\n&lt;0.001\n\n\nLiver Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n3.15\n3.01, 3.28\n&lt;0.001\n\n\nPeripheral Vascular Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.92\n0.89, 0.95\n&lt;0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.73\n0.72, 0.75\n&lt;0.001\n\n\nPrevious Heart Failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.96\n0.94, 0.99\n0.006\n\n\nAtrial Fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.38\n1.35, 1.41\n&lt;0.001\n\n\nSmoking\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.88\n0.86, 0.91\n&lt;0.001\n\n\nPrevious Stroke/TIA\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.94\n0.91, 0.96\n&lt;0.001\n\n\nPrevious PCI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.81\n0.79, 0.83\n&lt;0.001\n\n\nPrevious CABG\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.88\n0.85, 0.90\n&lt;0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nIschemic Stroke:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nChronic Kidney Disease\n\n\n\n\n\n\n\n\n    AMI without CKD\n—\n—\n\n\n\n\n    AMI with CKD\n0.23\n0.21, 0.25\n&lt;0.001\n\n\nAge, y\n1.00\n1.00, 1.01\n0.3\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.78\n0.73, 0.83\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.38\n1.17, 1.64\n&lt;0.001\n\n\n    Black\n1.01\n0.91, 1.12\n0.8\n\n\n    Hispanic\n1.04\n0.93, 1.17\n0.5\n\n\n    Native American\n0.61\n0.37, 1.01\n0.056\n\n\n    Other\n1.29\n1.08, 1.54\n0.006\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.96\n0.89, 1.05\n0.4\n\n\n    $66,000 - $87,999\n0.98\n0.89, 1.07\n0.6\n\n\n    $88,000 or more\n0.93\n0.84, 1.03\n0.2\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Medicaid\n—\n—\n\n\n\n\n    Medicare\n0.81\n0.71, 0.92\n&lt;0.001\n\n\n    Other\n1.09\n0.93, 1.27\n0.3\n\n\n    Private\n0.80\n0.70, 0.90\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.90\n0.81, 1.00\n0.061\n\n\n    South\n1.04\n0.95, 1.13\n0.4\n\n\n    West\n0.97\n0.87, 1.07\n0.5\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.88\n0.82, 0.95\n&lt;0.001\n\n\n    Small\n0.72\n0.65, 0.79\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.26\n1.07, 1.49\n0.006\n\n\n    Urban, teaching\n1.54\n1.33, 1.79\n&lt;0.001\n\n\nCharlson comorbidity index\n1.81\n1.78, 1.83\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.97\n0.89, 1.07\n0.6\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.84\n0.77, 0.92\n&lt;0.001\n\n\nDiabetes Mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.56\n0.52, 0.60\n&lt;0.001\n\n\nChronic Pulmonary Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.40\n0.37, 0.44\n&lt;0.001\n\n\nLiver Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.14\n1.01, 1.29\n0.029\n\n\nPeripheral Vascular Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.65\n0.60, 0.72\n&lt;0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.79\n0.74, 0.85\n&lt;0.001\n\n\nPrevious Heart Failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.83\n0.76, 0.90\n&lt;0.001\n\n\nAtrial Fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.56\n1.45, 1.68\n&lt;0.001\n\n\nSmoking\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.93\n0.84, 1.02\n0.12\n\n\nPrevious Stroke/TIA\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.58\n1.45, 1.72\n&lt;0.001\n\n\nPrevious PCI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.66\n0.60, 0.73\n&lt;0.001\n\n\nPrevious CABG\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.71\n0.63, 0.81\n&lt;0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio"
  },
  {
    "objectID": "quarto/index.html#multivariable-linear-regression",
    "href": "quarto/index.html#multivariable-linear-regression",
    "title": "Impact of Chronic Kidney Disease on In-Hospital Outcomes and Resource Utilization Among Patients Hospitalized for AMI",
    "section": "Multivariable Linear Regression:",
    "text": "Multivariable Linear Regression:\n\nLength of Stay:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nChronic Kidney Disease\n\n\n\n\n\n\n\n\n    AMI without CKD\n—\n—\n\n\n\n\n    AMI with CKD\n-0.69\n-0.77, -0.61\n&lt;0.001\n\n\nAge, y\n0.00\n0.00, 0.01\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.17\n0.13, 0.20\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n0.52\n0.38, 0.66\n&lt;0.001\n\n\n    Black\n0.05\n-0.02, 0.12\n0.13\n\n\n    Hispanic\n0.25\n0.17, 0.33\n&lt;0.001\n\n\n    Native American\n0.18\n-0.05, 0.41\n0.13\n\n\n    Other\n0.35\n0.22, 0.49\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-0.08\n-0.13, -0.03\n0.003\n\n\n    $66,000 - $87,999\n-0.17\n-0.23, -0.11\n&lt;0.001\n\n\n    $88,000 or more\n-0.23\n-0.30, -0.16\n&lt;0.001\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Medicaid\n—\n—\n\n\n\n\n    Medicare\n-0.37\n-0.46, -0.29\n&lt;0.001\n\n\n    Other\n-0.45\n-0.54, -0.37\n&lt;0.001\n\n\n    Private\n-0.52\n-0.59, -0.44\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.39\n0.29, 0.49\n&lt;0.001\n\n\n    South\n0.31\n0.23, 0.39\n&lt;0.001\n\n\n    West\n-0.36\n-0.45, -0.28\n&lt;0.001\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-0.72\n-0.79, -0.65\n&lt;0.001\n\n\n    Small\n-1.2\n-1.3, -1.1\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n0.82\n0.71, 0.93\n&lt;0.001\n\n\n    Urban, teaching\n1.6\n1.5, 1.7\n&lt;0.001\n\n\nCharlson comorbidity index\n0.75\n0.72, 0.77\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.07\n0.02, 0.12\n0.007\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.28\n0.24, 0.32\n&lt;0.001\n\n\nDiabetes Mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.43\n-0.48, -0.38\n&lt;0.001\n\n\nChronic Pulmonary Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.22\n-0.28, -0.17\n&lt;0.001\n\n\nLiver Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.2\n2.0, 2.3\n&lt;0.001\n\n\nPeripheral Vascular Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.34\n-0.41, -0.27\n&lt;0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.42\n-0.47, -0.37\n&lt;0.001\n\n\nPrevious Heart Failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.21\n-0.27, -0.15\n&lt;0.001\n\n\nAtrial Fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.8\n1.7, 1.8\n&lt;0.001\n\n\nSmoking\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.33\n-0.37, -0.29\n&lt;0.001\n\n\nPrevious Stroke/TIA\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.25\n-0.31, -0.20\n&lt;0.001\n\n\nPrevious PCI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.64\n-0.68, -0.60\n&lt;0.001\n\n\nPrevious CABG\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.0\n-1.1, -0.97\n&lt;0.001\n\n\n\nAbbreviation: CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nInflation-adjusted Total Charge:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nChronic Kidney Disease\n\n\n\n\n\n\n\n\n    AMI without CKD\n—\n—\n\n\n\n\n    AMI with CKD\n-14,424\n-16,654, -12,195\n&lt;0.001\n\n\nAge, y\n-567\n-620, -514\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n15,319\n14,356, 16,282\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n17,155\n11,378, 22,932\n&lt;0.001\n\n\n    Black\n-9,536\n-11,831, -7,241\n&lt;0.001\n\n\n    Hispanic\n15,022\n11,385, 18,660\n&lt;0.001\n\n\n    Native American\n-9,615\n-16,160, -3,070\n0.004\n\n\n    Other\n21,552\n15,966, 27,138\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-185\n-2,171, 1,801\n0.9\n\n\n    $66,000 - $87,999\n-1,112\n-3,487, 1,263\n0.4\n\n\n    $88,000 or more\n2,500\n-779, 5,779\n0.14\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Medicaid\n—\n—\n\n\n\n\n    Medicare\n1,540\n-654, 3,733\n0.2\n\n\n    Other\n680\n-1,936, 3,296\n0.6\n\n\n    Private\n285\n-1,966, 2,535\n0.8\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n10,008\n5,334, 14,682\n&lt;0.001\n\n\n    South\n22,505\n19,288, 25,721\n&lt;0.001\n\n\n    West\n37,775\n32,601, 42,948\n&lt;0.001\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-14,156\n-18,165, -10,147\n&lt;0.001\n\n\n    Small\n-28,428\n-32,293, -24,564\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n34,756\n30,423, 39,089\n&lt;0.001\n\n\n    Urban, teaching\n47,460\n43,596, 51,324\n&lt;0.001\n\n\nCharlson comorbidity index\n8,839\n8,133, 9,545\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1,603\n160, 3,047\n0.030\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n5,796\n4,403, 7,189\n&lt;0.001\n\n\nDiabetes Mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n663\n-715, 2,040\n0.3\n\n\nChronic Pulmonary Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-4,704\n-6,107, -3,302\n&lt;0.001\n\n\nLiver Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n80,884\n75,203, 86,564\n&lt;0.001\n\n\nPeripheral Vascular Disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1,183\n-3,100, 734\n0.2\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-2,010\n-3,375, -645\n0.004\n\n\nPrevious Heart Failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-10,795\n-12,330, -9,260\n&lt;0.001\n\n\nAtrial Fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n30,568\n28,879, 32,257\n&lt;0.001\n\n\nSmoking\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-8,818\n-10,151, -7,485\n&lt;0.001\n\n\nPrevious Stroke/TIA\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-12,195\n-13,541, -10,850\n&lt;0.001\n\n\nPrevious PCI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-14,880\n-16,115, -13,644\n&lt;0.001\n\n\nPrevious CABG\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-28,189\n-29,629, -26,750\n&lt;0.001\n\n\n\nAbbreviation: CI = Confidence Interval"
  }
]